Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Supplementation in HIV Patients on ART
NCT07553052Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Jun 2025
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Trial of vitamin d in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Universitas Sebelas Maret. Primary endpoints: Interleukin-6 Levels at 3 months and Cluster of Differentiation 4 Counts at 3 months. Started Jun 2025; status: completed.
02
Drugs
vitamin d
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07553052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07553052.